Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2025 is 18.16% vs 2.05% in Jun 2024
Consolidate Net Profit
YoY Growth in quarter ended Jun 2025 is 5.58% vs -10.85% in Jun 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2025 is -8.60% vs -5.33% in Jun 2024
Interest
YoY Growth in quarter ended Jun 2025 is 363.64% vs 0.00% in Jun 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024
Compare Quarterly Results Of ASKA Pharmaceutical Holdings Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 35.94% vs -19.04% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 18.16% vs 2.05% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 34.00% vs -34.79% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 5.58% vs -10.85% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 380.89% vs -84.31% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -8.60% vs -5.33% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 218.75% vs 23.08% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 363.64% vs 0.00% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024






